UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 27, 2007
PETMED EXPRESS, INC.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Florida 000-28827 65-0680967
--------------------------- ---------- ------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1441 S.W. 29th Avenue, Pompano Beach, Florida 33069
--------------------------------------------- --------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (954) 979-5995
--------------
-----------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-
2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-
4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02(e) Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers
On February 27, 2007, PetMed Express, Inc. (the "Company"), based
on the Compensation Committee recommendation that the Company's
Board of Directors amend the existing executive employment
agreement (the "Executive Employment Agreement") of Menderes
Akdag, the Company's Chief Executive Officer and President,
entered into Amendment No. 2 to the Executive Employment
Agreement with Mr. Akdag ("Agreement"). The Agreement amends
certain provisions of the Executive Employment Agreement as
follows: the term of the Agreement will be for three years,
commencing on March 16, 2007 (the "effective date"); Mr. Akdag's
salary will be increased to $450,000 per year throughout the term
of the Agreement, and Mr. Akdag shall be granted 90,000 shares of
restricted stock. The restricted stock was granted on February
27, 2007, in accordance with the Company's 2006 Restricted Stock
Plan and the restrictions shall lapse ratably over a three-year
period.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
10.1 Amendment No. 2 to Executive Employment Agreement dated
February 27, 2007 and effective March 16, 2007 between
the Company and Menderes Akdag.
10.2 Restricted Stock Agreement dated February 27, 2007
between the Company and Menderes Akdag.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
PETMED EXPRESS, INC.
Date: February 28, 2007 By:/s/ Menderes Akdag
----------------------
Menderes Akdag,
Chief Executive Officer
and President
By:/s/ Bruce S. Rosenbloom
------------------------
Bruce S. Rosenbloom,
Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
10.1 Amendment No. 2 to Executive Employment Agreement dated
February 27, 2007 and effective March 16, 2007 between the
Company and Menderes Akdag.
10.2 Restricted Stock Agreement dated February 27, 2007 between
the Company and Menderes Akdag.